International Stem Cell (ISCO) FCF Payout Ratio (2012)

International Stem Cell (ISCO) posted quarterly FCF Payout Ratio of 0.88 for Q4 2012, up 39.26% quarter-over-quarter from 0.63 in Q3 2012.

International Stem Cell (ISCO) FCF Payout Ratio (2012) Analysis & Trends

International Stem Cell (ISCO) has reported FCF Payout Ratio for 1 consecutive years, with 0.88 the latest figure, recorded in Q4 2012.

In Q4 2012, FCF Payout Ratio changed N/A year-over-year to 0.88; the TTM figure through Sep 2013 stood at 0.24 (changed N/A YoY), while the FY2010 annual figure was 0.07, changed N/A from the prior year.
FCF Payout Ratio improved to 0.88 in Q4 2012 per ISCO's latest filing, from 0.63 in the prior quarter.
Across five years, FCF Payout Ratio topped out at 0.88 in Q4 2012 and bottomed at 0.74 in Q2 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	0.17
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	0.07
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-
10	International Stem Cell	4.32 Mn	3.23 Mn	1.46 Mn	-

Download Data